Intellectus Partners LLC bought a new position in Colgate-Palmolive (NYSE:CL – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 8,282 shares of the company’s stock, valued at approximately $753,000.
Other institutional investors and hedge funds also recently modified their holdings of the company. Kohmann Bosshard Financial Services LLC bought a new position in shares of Colgate-Palmolive in the fourth quarter worth $26,000. Centricity Wealth Management LLC bought a new position in shares of Colgate-Palmolive in the fourth quarter worth $27,000. Union Bancaire Privee UBP SA bought a new position in shares of Colgate-Palmolive in the fourth quarter worth $32,000. Bernard Wealth Management Corp. bought a new position in shares of Colgate-Palmolive in the fourth quarter worth $36,000. Finally, Roxbury Financial LLC bought a new position in shares of Colgate-Palmolive in the fourth quarter worth $43,000. Institutional investors own 80.41% of the company’s stock.
Colgate-Palmolive Stock Up 3.8 %
Shares of Colgate-Palmolive stock opened at $96.84 on Friday. The stock has a 50-day moving average price of $88.84 and a 200 day moving average price of $95.17. The company has a market cap of $78.59 billion, a P/E ratio of 27.51, a P/E/G ratio of 4.20 and a beta of 0.40. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. Colgate-Palmolive has a 1 year low of $85.32 and a 1 year high of $109.30.
Colgate-Palmolive Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st were paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.07%. The ex-dividend date was Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 56.82%.
Analyst Ratings Changes
CL has been the subject of several research reports. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $101.00 target price on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. Stifel Nicolaus decreased their target price on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a research note on Monday, February 3rd. Piper Sandler decreased their target price on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research note on Monday, January 6th. TD Cowen decreased their target price on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. Finally, Barclays decreased their target price on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research note on Friday, January 17th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $101.61.
View Our Latest Stock Analysis on Colgate-Palmolive
Colgate-Palmolive Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also
- Five stocks we like better than Colgate-Palmolive
- How to start investing in penny stocks
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
- 3 Warren Buffett Stocks to Buy Now
- 3 Stocks to Buy While Others Stay on the Sidelines
- Why Invest in High-Yield Dividend Stocks?
- MarketBeat Week in Review – 03/03 – 03/07
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.